| 王海涛,吴彬,倪健.我国药品质量监督抽验情况分析及建议[J].中国药事,2017,(10):1107-1112 |
| 我国药品质量监督抽验情况分析及建议 |
| Analysis and Suggestions for Supervision and Sampling Test of Drug Quality in China |
| 投稿时间：2017-01-12 |
| DOI：10.16153/j.1002-7777.2017.10.003 |
| 中文关键词: 药品质量 监督抽验 问题 对策 |
| 英文关键词: drug quality supervision and sampling test problem countermeasures |
| 基金项目: |
|
| 摘要点击次数: 1236 |
| 全文下载次数: 664 |
| 中文摘要: |
| 目的：为完善我国药品监督抽验管理，提高我国药品监督抽验水平提供参考。方法：基于对我国现行药品抽验管理相关规定的了解，通过对国家食品药品监督管理总局（CFDA）2011-2014年公布的药品质量公告中相关数据进行统计分析，采用逻辑推理的方法对目前我国药品监督抽验存在的问题进行探讨。结果与结论：目前，我国药品监督抽验存在过于偏重国家基本药物、资源浪费、监管力量相对不足、检验技术未能有效发挥技术支撑作用等问题。建议通过合理制订抽验计划、改善抽验模式以及使用新兴药品监管技术，缓解目前我国药品监管中存在的问题。 |
| 英文摘要: |
| Objective: To provide suggestions for improving the management and level of supervision and sampling test of drugs in China. Methods: The relevant data of published drug quality announcement by CFDA from 2011 to 2014 were statistically analyzed based on the understanding of relevant provisions of management of current sampling test of drugs in China. Current problems of supervision and sampling test of drugs in China were discussed by using the method of logical reasoning. Results and Conclusion: The current problems of supervision and sampling test of drugs in China exist in the following aspects:overemphasis on national essential drugs, serious waste of resources, relative lack of supervision, and insufficient fulfillment of role of technical support of testing technologies. It was suggested that the problems in the current supervision of drugs in China should be alleviated by making a reasonable sampling test plan, improving the sampling test mode and utilizing the new regulatory technologies of drugs. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |